Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the bromomethyl group enables further functionalization through alkylation or coupling reactions. Its structure supports the construction of complex molecules in medicinal chemistry, especially in routes targeting central nervous system agents or anti-inflammatory compounds. The presence of both bromine and fluorine enhances reactivity and metabolic stability, making it valuable in optimizing drug candidates during research and development.